- Home
- WOOF vs COLL Comparison
WOOF vs COLL Comparison
Compare WOOF & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- COLL
- Stock Information
- Founded
- WOOF 1965
- COLL 2002
- Country
- WOOF United States
- COLL United States
- Employees
- WOOF N/A
- COLL N/A
- Industry
- WOOF Other Specialty Stores
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- WOOF Consumer Discretionary
- COLL Health Care
- Exchange
- WOOF Nasdaq
- COLL Nasdaq
- Market Cap
- WOOF 1.0B
- COLL 910.2M
- IPO Year
- WOOF 2021
- COLL 2015
- Fundamental
- Price
- WOOF $2.96
- COLL $29.71
- Analyst Decision
- WOOF Buy
- COLL Strong Buy
- Analyst Count
- WOOF 10
- COLL 5
- Target Price
- WOOF $3.85
- COLL $43.60
- AVG Volume (30 Days)
- WOOF 5.3M
- COLL 466.9K
- Earning Date
- WOOF 03-26-2025
- COLL 05-08-2025
- Dividend Yield
- WOOF N/A
- COLL N/A
- EPS Growth
- WOOF N/A
- COLL 43.56
- EPS
- WOOF N/A
- COLL 1.86
- Revenue
- WOOF $6,116,462,000.00
- COLL $631,449,000.00
- Revenue This Year
- WOOF $5.01
- COLL $19.43
- Revenue Next Year
- WOOF $2.13
- COLL $3.34
- P/E Ratio
- WOOF N/A
- COLL $16.00
- Revenue Growth
- WOOF N/A
- COLL 11.41
- 52 Week Low
- WOOF $1.41
- COLL $27.28
- 52 Week High
- WOOF $6.29
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- WOOF 57.93
- COLL 48.90
- Support Level
- WOOF $2.39
- COLL $29.33
- Resistance Level
- WOOF $3.42
- COLL $30.84
- Average True Range (ATR)
- WOOF 0.21
- COLL 0.85
- MACD
- WOOF 0.10
- COLL 0.08
- Stochastic Oscillator
- WOOF 59.65
- COLL 50.11
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.